These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36859298)

  • 1. Evaluation and guide for embedding opioid use disorder education in health professions' curricula.
    Salvador JG; Bolaños-Sacoman SL; Katzman JG; Morrison AE; Fox LE; Schneider JS; Bhatt SR; Kincaid TW; Waldorf VA
    BMC Med Educ; 2023 Mar; 23(1):135. PubMed ID: 36859298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in perceived clinical knowledge uptake among health profession students and licensed clinicians receiving buprenorphine waiver training in Oregon.
    Robbins JL; Bonuck K; Thuillier P; Buist C; Carney PA
    Subst Abus; 2022; 43(1):825-833. PubMed ID: 35130133
    [No Abstract]   [Full Text] [Related]  

  • 3. DATA 2000 waiver training for medical students: Lessons learned from a medical school experience.
    Zerbo E; Traba C; Matthew P; Chen S; Holland BK; Levounis P; Nelson LS; Lamba S
    Subst Abus; 2020; 41(4):463-467. PubMed ID: 32031914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update.
    Andrilla CHA; Moore TE; Patterson DG; Larson EH
    J Rural Health; 2019 Jan; 35(1):108-112. PubMed ID: 29923637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
    Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
    Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adapting and scaling a single site DEA X-waiver training program to a statewide initiative: Implementing GetWaiveredTX.
    Potter JS; Finley EP; King VL; Lanham HJ; Schmidt S; Schneegans S; Rosen KD
    J Subst Abuse Treat; 2022 Jun; 137():108688. PubMed ID: 35058105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Training in office-based opioid treatment with buprenorphine in US residency programs: A national survey of residency program directors.
    Tesema L; Marshall J; Hathaway R; Pham C; Clarke C; Bergeron G; Yeh J; Soliman M; McCormick D
    Subst Abus; 2018; 39(4):434-440. PubMed ID: 29513136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine Waiver Attitudes Among Primary Care Providers.
    Lai B; Croghan I; Ebbert JO
    J Prim Care Community Health; 2022; 13():21501319221112272. PubMed ID: 35822763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings.
    Speight C; Caiola C; Tyndall DE; Scott ES
    J Am Assoc Nurse Pract; 2023 Feb; 35(2):112-121. PubMed ID: 36512806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid stewardship training during the transition to residency to prepare medical students to recognize and treat opioid use disorder.
    Estave PM; Jacobs ML; Rukstalis M; Goforth J; Stone SN; Choi JA; Barrett J; Douglas HE; Oliver JB; Keating MK; Freischlag JA; O'Brien MC; McEwen S; Strowd RE
    Subst Abus; 2021; 42(4):1040-1048. PubMed ID: 34236292
    [No Abstract]   [Full Text] [Related]  

  • 11. Increasing North Carolina's Workforce Capacity for Prescribing Buprenorphine Products.
    Cabello-De la Garza A; Harless C; Ostrach B; Fagan B
    N C Med J; 2022; 83(4):288-293. PubMed ID: 35817448
    [No Abstract]   [Full Text] [Related]  

  • 12. Eight-hour medication-assisted treatment waiver training for opioid use disorder: integration into medical school curriculum.
    Lien IC; Seaton R; Szpytman A; Chou J; Webber V; Waineo E; Levine D
    Med Educ Online; 2021 Dec; 26(1):1847755. PubMed ID: 33222656
    [No Abstract]   [Full Text] [Related]  

  • 13. Characteristics and correlates of U.S. clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 pandemic.
    Jones CM; Diallo MM; Vythilingam M; Schier JG; Eisenstat M; Compton WM
    Drug Alcohol Depend; 2021 Aug; 225():108783. PubMed ID: 34049102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Training in Safe Opioid Prescribing and Treatment of Opioid Use Disorder in Internal Medicine Residencies: a National Survey of Program Directors.
    Windish DM; Catalanotti JS; Zaas A; Kisielewski M; Moriarty JP
    J Gen Intern Med; 2022 Aug; 37(11):2650-2660. PubMed ID: 34729698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are North Carolina clinicians delivering opioid use disorder treatment to Medicaid beneficiaries?
    Grove LR; Rao N; Domino ME
    Addiction; 2022 Nov; 117(11):2855-2863. PubMed ID: 35194878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing the opioid crisis: An assessment of clinicians' training experience, practices, and attitudes within a large healthcare organization.
    Kirane H; Drits E; Ahn S; Kapoor S; Morgenstern J; Conigliaro J; Enden J
    J Opioid Manag; 2019; 15(3):193-204. PubMed ID: 31343721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "It's that longitudinal relationship that pays off": A qualitative study of internal medicine residents' perspectives on learning to prescribe buprenorphine.
    Logan AA; Jack HE; Darnton J; Klein JW
    Subst Abus; 2021; 42(4):944-950. PubMed ID: 33797320
    [No Abstract]   [Full Text] [Related]  

  • 18. Increasing Short- and Long-Term Buprenorphine Treatment Capacity: Providing Waiver Training for Medical Students.
    Stokes DC; Perrone J
    Acad Med; 2022 Feb; 97(2):182-187. PubMed ID: 33538477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment.
    Haffajee RL; Bohnert ASB; Lagisetty PA
    Am J Prev Med; 2018 Jun; 54(6 Suppl 3):S230-S242. PubMed ID: 29779547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How a Medication for Opioid Use Disorder Curriculum Translates into Experiences and Internal Medicine Residents' Understanding of Patients with Opioid Use Disorder.
    Robles M; Mortazavi L; Vannerson J; Matthias MS
    Teach Learn Med; 2022; 34(5):514-521. PubMed ID: 33974460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.